Drawing for CHANRX

USPTO serial 85099947

CHANRX

Reviewed by CopyMark Law Group

Reg. 4050397Status 710
Filing date
Status date
Registration date
Nov 1, 2011
Examiner
HWANG, JOHN C B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CHANRX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rushna Tejani Heneghan

Rushna Tejani Heneghan Charles River251 Ballardvale StreetWilmington, MA 01887UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Biochemical research and development; Biomedical research services; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Drug discovery services; Medical research; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Scientific research; Scientific research and developmentSECTION 8 - CANCELLEDApr 1, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 8, 2018C8..CANCELLED SEC. 8 (6-YR)—
Nov 1, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 3, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 3, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 16, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 16, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 1, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 24, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 23, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Sep 21, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 21, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 19, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 15, 2011IUAFUSE AMENDMENT FILED—
Sep 15, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 15, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 18, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 18, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 10, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 10, 2010ALIEASSIGNED TO LIE—
Nov 18, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 18, 2010DOCKASSIGNED TO EXAMINER—
Aug 9, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 7, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance